Stephanie Okey
Director/Board Member at PTC THERAPEUTICS, INC.
Net worth: 567 891 $ as of 2024-03-30
Profile
Stephanie Smith Okey is an Independent Director who currently holds positions at PTC Therapeutics, Inc., Catalent, Inc., and Crinetics Pharmaceuticals, Inc. She previously held positions as a Director at Orphazyme A, an Independent Director at Albireo Pharma, Inc., and a Director at California Life Sciences Association.
She also served as the GM-Rare Disease Business Unit & Senior VP at Genzyme Corp.
Ms. Okey received her undergraduate degree from The Ohio State University and her graduate degree from Wright State University (Ohio).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.01% | 2024-02-14 | 9,867 ( 0.01% ) | 287 031 $ | 2024-03-30 |
| 2024-03-27 | 6,000 ( 0.01% ) | 280 860 $ | 2024-03-30 |
Stephanie Okey active positions
| Companies | Position | Start |
|---|---|---|
| PTC THERAPEUTICS, INC. | Director/Board Member | 2018-12-17 |
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 2019-07-14 |
| CATALENT, INC. | Director/Board Member | 2023-08-28 |
Former positions of Stephanie Okey
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 2023-03-01 |
| ORPHAZYME A/S | Director/Board Member | 2022-05-22 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | 2015-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2015-06-30 |
Training of Stephanie Okey
| The Ohio State University | Undergraduate Degree |
| Wright State University (Ohio) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| CATALENT, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Stephanie Okey
